New blood clot drug put to the test in healthy volunteers
NCT ID NCT06517563
First seen Sep 30, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This early-stage study looked at how a new drug called VMX-C001 interacts with common blood thinners (heparin and rivaroxaban) in 16 healthy adults. Researchers measured changes in blood clotting times to understand the drug's effects. The goal was to gather safety and activity data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COAGULATION DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.